Global Distribution Partners
EXCLUSIVE DISTRIBUTORS IN ITALY
AB ANALITICA srl
Via Svizzera 16 – 35127 Padova – Italy
Tel: +39 049 761698 – Fax: +39 049 8709510
Email: info@abanalitica.it
www.abanalitica.it
EXCLUSIVE DISTRIBUTORS FOR THE MIDDLE EAST NORTH AFRICAN REGION
EILAF PHARMA, S.A.E.
5 Mustafa Refaat St
Cairo 11799 – Egypt
Tel: +2 (02) 2267 9961 – Fax: +2 (02) 2267 9962
Email: innovation@eilaf.info
www.eilaf.info
EXCLUSIVE DISTRIBUTORS OF MY5-FU IN JAPAN
FALCO BIOSYSTEMS LTD.
Nakagayo-ku, Kyoto 604-0911 – Japan
Tel: +81 (75) 257-8583 – Fax: +81 (75) 257-8557
www.falco.co.jp
EXCLUSIVE DISTRIBUTORS IN POLAND
GENOXA SP. Z O.O.
Rzucewo 2, 84-100, Puck – Poland
Tel: +48 58 739 58 89
Email: office@genoxa.pl
www.genoxa.pl
EXCLUSIVE DISTRIBUTORS IN ISRAEL
Ilex Medical, Ltd.
7 Hatnufa St – Kiriat Arie Industrial Park – 49002 Petach Tikva – Israel
Tel: +972-3-9385535 – Fax: +972-3-9385505
Email: sales@ilexmedical.com
www.ilexmedical.com
EXCLUSIVE DISTRIBUTORS IN SPAIN & PORTUGAL
Inydia Lab Medical Diagnostics, S.L.
C/Sesmo de Casarrubios, 10A, Edificio Sabinar. Loft 1
28210 Valdemorillo, Spain
Email: info@inydia.com
www.inydia.com
EXCLUSIVE DISTRIBUTORS IN TURKEY
KAAN MEDIKAL TIC. LTD.
Uskudar, TR-34692, Istanbul – Turkey
Tel: +90 (216) 328 1407 – Fax: +90 (216) 328 1644
www.kaanmed.com
EXCLUSIVE LICENSEES OF MY5-FU (MARKETED AS OnDose®) IN NORTH AMERICA
MYRIAD GENETICS, INC.
320 Wakara Way, Salt Lake City, UT 84108 – USA
Tel: + (801) 584-3600 – Fax: + (801) 584-3640
www.myriad.com
www.ondose.com
DIRECT DISTRIBUTION IN UK, IRELAND, FRANCE, GERMANY, AUSTRIA SWITZERLAND, AUSTRALIA AND NEW ZEALAND
SALADAX BIOMEDICAL, INC.
116 Research Drive, Bethlehem, PA 18015 – USA
Tel: + 610 419-6731, ext. 26503
www.saladax.com
Partnering Opportunities
Saladax Biomedical actively pursues strategic alliances for co-promotion and/or distribution of its proprietary line of MyCare™ products. We seek leaders in the in vitro diagnostic industry that promote to the oncology community, major reference laboratories that would offer MyCare testing services, and pharmaceutical companies that market anti-cancer drugs that would further enhance patient outcomes via the Saladax MyCare technology platform.
Partnering contact: Mark Myslinski
Sr. VP & Chief Commercial Officer
Saladax Biomedical, Inc.
116 Research Drive
Bethlehem, PA 18015
E-mail: mmyslinski@saladax.com
Phone: (610) 419-6731 x26524
Fax: (610) 849-5001
